Image

Brain Stimulation to the Hippocampus in Schizophrenia

Brain Stimulation to the Hippocampus in Schizophrenia

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

Schizophrenia - marked by delusions, hallucinations, and cognitive deficits - causes the most disability of any mental health condition, but existing treatments have significant side effect burden and are often ineffective. Disordered neural activity in the hippocampus likely contributes to schizophrenia symptoms, but to develop better therapies we need to understand whether hippocampal activity in schizophrenia can be systematically affected by non-invasive brain stimulation techniques like transcranial magnetic stimulation (TMS). This proposal will investigate the use of connectivity-guided theta burst brain stimulation to specifically target hippocampal function in schizophrenia, offering insights into fundamental hippocampal processes, schizophrenia pathophysiology, and potential avenues to use brain stimulation as a therapeutic tool in this devastating illness.

Eligibility

Inclusion Criteria:

  • Men and women, ages 18 to 65 years
  • Medically intractable epilepsy requiring phase II monitoring (intracranial EEG arms only)
  • DSM-V diagnosis of schizophrenia spectrum Axis I disorders including delusional disorder, brief psychotic disorder, schizophreniform disorder, schizophrenia, schizoaffective disorder (non-invasive TMS-EEG arms only).
  • Must have intellectual capacity to ensure adequate comprehension of the study and potential risks involved in order to provide informed consent
  • No current or history of major neurological disorders other than epilepsy.

Exclusion Criteria:

  • DSM5 diagnosis of intellectual disability
  • Significant head injury
  • Active suicidal ideation or history of suicide attempt within the past 1 year.
  • Medical illness affecting brain structure or function, or other uncontrolled or unstable medical condition.
  • Pregnancy or postpartum (\<6 weeks after delivery or miscarriage)
  • Inability to provide informed consent
  • Active substance abuse other than alcohol or cannabis within the past 1 year
  • Psychotic illness with a temporal relation to substance use or head injury
  • Those with a contraindication for MRIs or TMS (e.g. implanted metal).

Study details
    Schizophrenia Disorders
    Mental Disorder
    Psychotic Disorder

NCT07010614

Stanford University

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.